UK Biotech Star Cell Medica Eyes Nasdaq Float

A rising star of the UK biotech sector is exploring a flotation on New York's Nasdaq stock exchange despite a pledge to overhaul drug pricing made by Hillary Clinton, the US Democratic presidential hopeful. Sky News has learnt that Cell Medica, which counts Neil Woodford, the UK's best-known fund manager, among its leading shareholders, is in talks with investment banks about a listing that could take place as soon as next year. Cell Medica, which specialises in cellular immunotherapy to treat c